Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply
- PMID: 38507772
- DOI: 10.1056/NEJMc2400767
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply
Comment on
-
Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.N Engl J Med. 2023 Dec 14;389(24):2245-2255. doi: 10.1056/NEJMoa2302099. N Engl J Med. 2023. PMID: 38091531
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical